Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer
10-03-2023
We would like to inform you about a landmark study that has been recently pulished and may be of interest:
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer
Authors: Johan Maertens, Tom Lodewyck, J Peter Donnelly, Sylvain Chantepie, Christine Robin, Nicole Blijlevens, Pascal Turlure, Dominik Selleslag, Frédéric Baron, Mickael Aoun, Werner J Heinz, Hartmut Bertz, Zdeněk Ráčil, Bernard Vandercam, Lubos Drgona, Valerie Coiteux, Cristina Castilla Llorente, Cornelia Schaefer-Prokop, Marianne Paesmans, Lieveke Ameye, Liv Meert, Kin Jip Cheung, Deborah A Hepler, Jürgen Loeffler, Rosemary Barnes, Oscar Marchetti, Paul Verweij, Frederic Lamoth, Pierre-Yves Bochud, Michael Schwarzinger, Catherine Cordonnier, for the Infectious Diseases Group and the Acute Leukemia Group of the European Organization for Research and Treatment of Cancer
Clinical Infectious Diseases, Volume 76, Issue 4, 15 February 2023, Pages 674–682,
< back
